Korean Journal of Radiology

  • 제12권1호
  • /
  • Pages.97-106
  • /
  • 2011
  • /
  • 1229-6929(pISSN)
  • /
  • 2005-8330(eISSN)
대한영상의학회 (The Korean Society of Radiology)
권호 표지
DOI QR코드

DOI QR Code

Catheter-Directed Thrombolysis with a Continuous Infusion of Low-Dose Urokinase for Non-Acute Deep Venous Thrombosis of the Lower Extremity

  • Gao, Binbin (Department of Vascular Surgery, Shandong Provincial Hospital, Shandong University) ;
  • Zhang, Jing-Yong (Department of Vascular Surgery, Shandong Provincial Hospital, Shandong University) ;
  • Wu, Xuejun (Department of Vascular Surgery, Shandong Provincial Hospital, Shandong University) ;
  • Han, Zong-Lin (Department of Vascular Surgery, Shandong Provincial Hospital, Shandong University) ;
  • Zhou, Hua (Department of Vascular Surgery, Shandong Provincial Hospital, Shandong University) ;
  • Dong, Dianning (Department of Vascular Surgery, Shandong Provincial Hospital, Shandong University) ;
  • Jin, Xing (Department of Vascular Surgery, Shandong Provincial Hospital, Shandong University)
  • 발행 : 2011.02.01
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: We wanted to evaluate the feasibility of catheter-directed thrombolysis with a continuous infusion of low-dose urokinase for treating non-acute (less than 14 days) deep venous thrombosis of the lower extremity. Materials and Methods: The clinical data of 110 patients who were treated by catheter-directed thrombolysis with a continuous infusion of low-dose urokinase for lower extremity deep venous thrombosis was analysed. Adjunctive angioplasty or/and stenting was performed for the residual stenosis. Venous recanalization was graded by pre- and posttreatment venography. Follow-up was performed by clinical evaluation and Doppler ultrasound. Results: A total of 112 limbs with deep venous thrombosis with a mean symptom duration of 22.7 days (range: 15-38 days) were treated with a urokinase infusion (mean: 3.5 million IU) for a mean of 196 hours. After thrombolysis, stent placement was performed in 25 iliac vein lesions and percutaneous angioplasty (PTA) alone was done in five iliac veins. Clinically significant recanalization was achieved in 81% (90 of 112) of the treated limbs; complete recanalization was achieved in 28% (31 of 112) and partial recanalization was achieved in 53% (59 of 112). Minor bleeding occurred in 14 (13%) patients, but none of the patients suffered from major bleeding or symptomatic pulmonary embolism. During followup (mean: 15.2 months, range: 3-24 months), the veins were patent in 74 (67%) limbs. Thirty seven limbs (32%) showed progression of the stenosis with luminal narrowing more than 50%, including three with rethrombosis, while one revealed an asymptomatic iliac vein occlusion; 25 limbs (22%) developed mild post-thrombotic syndrome, and none had severe post-thrombotic syndrome. Valvular reflux occurred in 24 (21%) limbs. Conclusion: Catheter-directed thrombolysis with a continuous infusion of low-dose urokinase combined with adjunctive iliac vein stenting is safe and effective for removal of the clot burden and for restoration of the venous flow in patients with non-acute lower extremity deep venous thrombosis.

키워드

참고문헌

  1. Blum A, Roche E. Endovascular management of acute deep vein thrombosis. Am J Med 2005;118:31S-36S https://doi.org/10.1016/j.amjmed.2005.06.007
  2. Baekgaard N, Broholm R, Just S, Jorgensen M, Jensen LP. Long-term results using catheter-directed thrombolysis in 103 lower limbs with acute iliofemoral venous thrombosis. Eur J Vasc Endovasc Surg 2010;39:112-117 https://doi.org/10.1016/j.ejvs.2009.09.015
  3. Grossman C, McPherson S. Safety and efficacy of catheterdirected thrombolysis for iliofemoral venous thrombosis. AJR Am J Roentgenol 1999;172:667-672 https://doi.org/10.2214/ajr.172.3.10063857
  4. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:454S-545S https://doi.org/10.1378/chest.08-0658
  5. Vedantham S, Millward SF, Cardella JF, Hofmann LV, Razavi MK, Grassi CJ, et al. Society of Interventional Radiology position statement: treatment of acute iliofemoral deep vein thrombosis with use of adjunctive catheter-directed intrathrombus thrombolysis. J Vasc Interv Radiol 2006;17:613-616 https://doi.org/10.1097/01.RVI.0000203802.35689.66
  6. Lou WS, Gu JP, He X, Chen L, Su HB, Chen GP, et al. Endovascular treatment for iliac vein compression syndrome: a comparison between the presence and absence of secondary thrombosis. Korean J Radiol 2009;10:135-143 https://doi.org/10.3348/kjr.2009.10.2.135
  7. Patel N, Sacks D, Patel RI, Moresco KP, Ouriel K, Gray R, et al. SIR reporting standards for the treatment of acute limb ischemia with use of transluminal removal of arterial thrombus. J Vasc Interv Radiol 2003;14:S453-S465 https://doi.org/10.1097/01.RVI.0000094619.61428.11
  8. Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional radiology clinical practice guidelines. J Vasc Interv Radiol 2003;14:S199-S202 https://doi.org/10.1097/01.RVI.0000094584.83406.3e
  9. Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 1999;211:39-49 https://doi.org/10.1148/radiology.211.1.r99ap4739
  10. Vedantham S, Grassi CJ, Ferral H, Patel NH, Thorpe PE, Antonacci VP, et al. Reporting standards for endovascular treatment of lower extremity deep vein thrombosis. J Vasc Interv Radiol 2006;17:417-434 https://doi.org/10.1097/01.RVI.0000197359.26571.C2
  11. Park YJ, Choi JY, Min SK, Lee T, Jung IM, Chung JK, et al. Restoration of patency in iliofemoral deep vein thrombosis with catheter-directed thrombolysis does not always prevent post-thrombotic damage. Eur J Vasc Endovasc Surg 2008;36:725-730 https://doi.org/10.1016/j.ejvs.2008.08.020
  12. Prandoni P, Lensing AW, Prins MH, Frulla M, Marchiori A, Bernardi E, et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med 2004;141:249-256 https://doi.org/10.7326/0003-4819-141-4-200408170-00004
  13. Mattos MA, Sumner DS. Direct noninvasive tests (duplex scan) for the evaluation of chronic venous obstruction and valvular incompetence. In: Gloviczki P, Yao JS, eds. Handbook of venous disorders, 2nd ed. New York, NY: Arnold; 2001: 120-131
  14. Kolbel T, Lindh M, Akesson M, Wasselius J, Gottsater A, Ivancev K. Chronic iliac vein occlusion: midterm results of endovascular recanalization. J Endovasc Ther 2009;16:483-491 https://doi.org/10.1583/09-2719.1
  15. See-Tho K, Harris EJ Jr. Thrombosis with outfl ow obstruction delays thrombolysis and results in chronic wall thickening of rat veins. J Vasc Surg 1998;28:115-122 https://doi.org/10.1016/S0741-5214(98)70206-X
  16. Gogalniceanu P, Johnston CJ, Khalid U, Holt PJ, Hincliffe R, Loftus IM, et al. Indications for thrombolysis in deep venous thrombosis. Eur J Vasc Endovasc Surg 2009;38:192-198 https://doi.org/10.1016/j.ejvs.2009.03.023
  17. Beygui RE, Olcott C 4th, Dalman RL. Subclavian vein thrombosis: outcome analysis based on etiology and modality of treatment. Ann Vasc Surg 1997;11:247-255 https://doi.org/10.1007/s100169900042
  18. Kim HS, Patra A, Paxton BE, Khan J, Streiff MB. Catheterdirected thrombolysis with percutaneous rheolytic thrombectomy versus thrombolysis alone in upper and lower extremity deep vein thrombosis. Cardiovasc Intervent Radiol 2006;29:1003-1007 https://doi.org/10.1007/s00270-005-0341-4
  19. Vedantham S, Vesely TM, Sicard GA, Brown D, Rubin B, Sanchez LA, et al. Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis. J Vasc Interv Radiol 2004;15:565-574 https://doi.org/10.1097/01.RVI.0000127894.00553.02
  20. Jackson LS, Wang XJ, Dudrick SJ, Gersten GD. Catheterdirected thrombolysis and/or thrombectomy with selective endovascular stenting as alternatives to systemic anticoagulation for treatment of acute deep vein thrombosis. Am J Surg 2005;190:864-868 https://doi.org/10.1016/j.amjsurg.2005.08.009
  21. Kwak HS, Han YM, Lee YS, Jin GY, Chung GH. Stents in common iliac vein obstruction with acute ipsilateral deep venous thrombosis: early and late results. J Vasc Interv Radiol 2005;16:815-822 https://doi.org/10.1097/01.RVI.0000157690.91690.38
  22. Bjarnason H, Kruse JR, Asinger DA, Nazarian GK, Dietz CA Jr, Caldwell MD, et al. Iliofemoral deep venous thrombosis: safety and effi cacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Interv Radiol 1997;8:405-418 https://doi.org/10.1016/S1051-0443(97)70581-5
  23. Ouriel K, Gray B, Clair DG, Olin J. Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis. J Vasc Interv Radiol 2000;11:295-298 https://doi.org/10.1016/S1051-0443(07)61420-1
  24. Alesh I, Kayali F, Stein PD. Catheter-directed thrombolysis (intrathrombus injection) in treatment of deep venous thrombosis: a systematic review. Catheter Cardiovasc Interv 2007;70:143-148
  25. Segal JB, Streiff MB, Hofmann LV, Thornton K, Bass EB. Management of venous thromboembolism: a systematic review for a practice guideline. Ann Intern Med 2007;146:211-222 https://doi.org/10.7326/0003-4819-146-3-200702060-00150
  26. Kahn SR, Solymoss S, Lamping DL, Abenhaim L. Long-term outcomes after deep vein thrombosis: postphlebitic syndrome and quality of life. J Gen Intern Med 2000;15:425-429 https://doi.org/10.1046/j.1525-1497.2000.06419.x
  27. Kahn SR, Ginsberg JS. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med 2004;164:17-26 https://doi.org/10.1001/archinte.164.1.17
  28. Kahn SR. The post-thrombotic syndrome: the forgotten morbidity of deep venous thrombosis. J Thromb Thrombolysis 2006;21:41-48 https://doi.org/10.1007/s11239-006-5574-9
  29. Markel A, Manzo RA, Bergelin RO, Strandness DE Jr. Valvular refl ux after deep vein thrombosis: incidence and time of occurrence. J Vasc Surg 1992;15:377-382 https://doi.org/10.1016/0741-5214(92)90259-B
  30. Cho JS, Martelli E, Mozes G, Miller VM, Gloviczki P. Effects of thrombolysis and venous thrombectomy on valvular competence, thrombogenicity, venous wall morphology, and function. J Vasc Surg 1998;28:787-799 https://doi.org/10.1016/S0741-5214(98)70053-9

피인용 문헌

  1. Management of proximal deep vein thrombosis vol.27, pp.2, 2011, https://doi.org/10.1258/phleb.2012.012s37
  2. Fixed low-dose ultrasound-assisted catheter-directed thrombolysis followed by routine stenting of residual stenosis for acute ilio-femoral deep-vein thrombosis vol.111, pp.6, 2011, https://doi.org/10.1160/th13-11-0932
  3. Single-Session Endovascular Treatment of Symptomatic Lower Extremity Deep Vein Thrombosis : Is it Possible Even for Aged Thrombosis vol.50, pp.5, 2011, https://doi.org/10.1177/1538574416652241
  4. Effectiveness of catheter directed thrombolysis and stent implantation on iliofemoral vein thrombosis caused by iliac vein compression vol.44, pp.2, 2011, https://doi.org/10.1007/s11239-017-1515-z
  5. Feasibility of continuous, catheter-directed thrombolysis using low-dose urokinase in combination with low molecular-weight heparin for acute iliofemoral venous thrombosis in patients at risk of bleed vol.13, pp.2, 2011, https://doi.org/10.3892/etm.2017.4023